W
Wenyan Zhang
Researcher at Sichuan University
Publications - 72
Citations - 1228
Wenyan Zhang is an academic researcher from Sichuan University. The author has contributed to research in topics: Lymphoma & Diffuse large B-cell lymphoma. The author has an hindex of 13, co-authored 62 publications receiving 955 citations.
Papers
More filters
Journal ArticleDOI
Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells
Can Küçük,Bei Jiang,Xiaozhou Hu,Wenyan Zhang,John K.C. Chan,Wenming Xiao,Nathan A. Lack,Can Alkan,John C. Williams,Kendra N. Avery,Painar Kavak,Anna Scuto,Emel Sen,Philippe Gaulard,Lou Staudt,Javeed Iqbal,Weiwei Zhang,Adam Cornish,Qiang Gong,Qun-Pei Yang,Hong Sun,Francesco d'Amore,Sirpa Leppä,Weiping Liu,Kai Fu,Laurence de Leval,Timothy W. McKeithan,Wing C. Chan +27 more
TL;DR: The findings suggest that JAK-STAT pathway inhibition may represent a therapeutic strategy in NK/T-cell lymphomas and their cell lines through next generation and/or Sanger sequencing.
Journal ArticleDOI
Subtype distribution of lymphomas in Southwest China: Analysis of 6,382 cases using WHO classification in a single institution
Qun-Pei Yang,Wenyan Zhang,Jian-bo Yu,Sha Zhao,Huan Xu,Wei-Ya Wang,Cheng-feng Bi,Zhuo Zuo,Xiao-Qing Wang,Juan Huang,Lin Dai,Weiping Liu +11 more
TL;DR: The lymphoid neoplasms of Southwest China displayed some epidemiologic features similar to those reported in literature from western and Asian countries, as well as other regions of China, whereas some subtypes showed distinct features.
Journal ArticleDOI
Phase 2 trial of “Sandwich” L‐asparaginase, vincristine, and prednisone chemotherapy with radiotherapy in newly diagnosed, stage IE to IIE, nasal type, extranodal natural killer/T‐cell lymphoma
Ming Jiang,Hong Zhang,Yu Jiang,Qun-pei Yang,Li Xie,Weiping Liu,Wenyan Zhang,Xiaohui Ji,Ping Li,Nianyong Chen,Sha Zhao,Feng Wang,Liqun Zou +12 more
TL;DR: Extranodal natural killer/T‐cell lymphoma (ENKTL), nasal‐type, is a distinct entity of lymphoid tissue that is sensitive to radiotherapy (RT), but the prognosis is poorer than for other types of early lymphoma.
Journal ArticleDOI
Five-year analysis from phase 2 trial of "sandwich" chemoradiotherapy in newly diagnosed, stage IE to IIE, nasal type, extranodal natural killer/T-cell lymphoma.
Li Zhang,Ming Jiang,Li Xie,Hong Zhang,Yu Jiang,Qun-pei Yang,Weiping Liu,Wenyan Zhang,Hong-yu Zhuo,Ping Li,Nianyong Chen,Sha Zhao,Feng Wang,Liqun Zou +13 more
TL;DR: The results indicate that the “sandwich” protocol may benefit the long‐term survival of patients with newly diagnosed stage IE‐IIE, nasal type, extranodal natural killer/T‐cell lymphoma, however, additional studies with larger samples are required to confirm these results.
Journal ArticleDOI
Extranodal nasal-type natural killer/T-cell lymphoma of the skin: a clinicopathologic study of 16 cases in China.
Jian-bo Yu,Zhuo Zuo,Yuan Tang,Sha Zhao,Ying-Chun Zhang,Cheng-Feng Bi,Wei-Ya Wang,Wenyan Zhang,Lin Wang,Weiping Liu +9 more
TL;DR: Both primary and secondary cutaneous natural killer/T-cell lymphomas are highly aggressive and the outcome is closely related to the number and distribution of the lesions as well as the stage.